Frequently Asked Questions
The market is segmented based on Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market, By Type (Software and Services), Product (Standard Form and Customized Form), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, and Issue Tracking Software), By Delivery (On-Premise Delivery Mode and On-Demand/Cloud-Based (SAAS) Delivery Mode), End Users (Biotechnology and Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, and Healthcare Providers), Distribution Channel (Direct Sales and Retail Sales), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia- Pacific) - Industry Trends and Forecast to 2030.
.
The Asia Pacific Drug Safety Solutions And Pharmacovigilance Market size was valued at USD 1220.34 USD million in 2022.
The Asia Pacific Drug Safety Solutions And Pharmacovigilance Market is projected to grow at a CAGR of 8.1% during the forecast period of 2023 to 2030.
The market report covers data from the Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific.
